Page last updated: 2024-08-24

brequinar and Thrombopenia

brequinar has been researched along with Thrombopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armand, JP; Barbu, M; Carde, P; Chabot, GG; de Forni, M; Domenge, C; Fontana, X; Gouyette, A; Recondo, G1
Donatsch, P; Dorobek, B; Jaffee, B; Magolda, R; Pally, C; Papageorgiou, C; Schuurman, HJ; Smith, D; Zehender, H1

Trials

1 trial(s) available for brequinar and Thrombopenia

ArticleYear
Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Half-Life; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Thrombocytopenia

1993

Other Studies

1 other study(ies) available for brequinar and Thrombopenia

ArticleYear
Side effects of brequinar and brequinar analogues, in combination with cyclosporine, in the rat.
    Toxicology, 1998, May-15, Volume: 127, Issue:1-3

    Topics: Administration, Oral; Animals; Biphenyl Compounds; Blood Cell Count; Body Weight; Bone Marrow; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Immunosuppressive Agents; Jejunum; Leukopenia; Male; Rats; Rats, Inbred Lew; Spleen; Thrombocytopenia; Thymus Gland; Toxicity Tests; Weight Gain

1998